WHA21.37 Quality  Control  of Drugs 
The Twenty-first  World  Health  Assembly, 
Recalling  resolution  WHA20.34; 
Having  noted  resolution  EB41.R28  of the Executive  Board; 
Having  considered  the report  of the Director-General  on the quality  control  of drugs; 
Noting  with  satisfaction  that  progress  has  been  made  in the establishment  of principles  for good  manufacturing  practice;  and 
Considering  the  further  action  as outlined  in the Director-General's  report  with  particular  reference  to 
the suggestions  concerning  the principles  which  might  be included  in regulations  and  recommendations, 
REQUESTS  the  Director-General: 
(i) to  report  to the  Twenty-second  World  Health  Assembly  on the  final  formulation  of generally 
acceptable  requirements  for good  manufacturing  practice  in the production  and  quality  control  of drugs; 
(ii) to  report  to the Twenty-second  World  Health  Assembly  on the inclusion  of a certification  scheme 
on the quality  of pharmaceutical  products  in international  commerce  and  of the requirements  for good 
manufacturing  practice  in regulations  and  recommendations  respectively;  and 
(iii) to  continue  assistance  in the establishment  or development  of control  laboratories  on a national 
or, preferably,  zonal  or regional  basis,  complying  with  the  need  of those  countries  which  do not  yet 
have  the  facilities  necessary  for  this  purpose. 
Handb.  Res.,  9th Ã©d.,  1.10.4.1 Seventeenth  plenary  meeting,  23 May  1968  (Committee 
on Programme  and  Budget,  fourth  report) 
